Loading
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Apr 2025 for AIM ImmunoTech Inc., €39. Read the official filing
Filing timeline
BuySalePeter W. Rodino III
Insider track record
Disclosed buys
4
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-23.8%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Peter W. Rodino III: trading record in brief
Peter W. Rodino III (chief executive) discloses dealings in AIM ImmunoTech Inc. to SEC (Form 4). The record holds 6 filings, for trades running from 25 April 2022 to 4 April 2025.
Purchases make up the whole of the open-market record (4 purchases, €47k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants. 2025 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €12k. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
The record was last updated on 4 April 2025 with an open-market purchase (€39) in AIM ImmunoTech Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Peter W. Rodino III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
500 shares@ US$0.0870.0% of flowCommon StockSEC:0001641172-25-002827:0
Canonical exit: 3 Jul 2025 (T+90)
188,679 shares@ US$0.26547.2% of flowCommon StockSEC:0001493152-24-031416:0
30,865 shares@ US$0.40512.0% of flowCommon StockSEC:0001493152-24-018028:0
Canonical exit: 4 Aug 2024 (T+90)
37,879 shares@ US$0.3311.8% of flowCommon StockSEC:0001493152-24-010268:0
Canonical exit: 13 Jun 2024 (T+90)
80,646 shares@ US$0.3124.2% of flowCommon StockSEC:0001493152-23-000213:0
Canonical exit: 3 Apr 2023 (T+90)
4,902 shares@ US$1.024.8% of flowCommon StockSEC:0001450324-22-000003:0
6 of 6 declarations
